Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2011

Dec 7, 2011

29777_dirs_2011-12-06_e3144c05-34a6-41e6-98d9-51df17f4f9e8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2011-11-21

Reporting Person: Landgraf John C (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-11-21 Common shares without par value G 609 Disposed 88111 Direct
2011-12-02 Common shares without par value M 53201 $53.625 Acquired 141312 Direct
2011-12-02 Common shares without par value S 53197 $54.63 Disposed 88115 Direct
2011-12-02 Common shares without par value S 4 $54.635 Disposed 88111 Direct
2011-11-22 Common shares without par value G 12954 Disposed 0 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-12-02 Option (right to buy) $53.625 M 53201 Disposed 2012-02-14 Common shares (53201) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 17604 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of December 2, 2011.

F2: Shares were formerly held in the Anne Marie Landgraf Living Trust. The reporting person and his spouse are co-trustees of the trust. The trust is revocable by his spouse.

F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.